Inoviq Ltd has released a press release.
Cancer Vaccine Collaboration
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Ovarian cancer clinical study results
- Appendix 4D and Half Yearly Reports and Accounts
- Successful Assay Feasibility Results
- Quarterly Activities Review and Appendix 4C
- Appointment of CEO
Later from Inoviq
- Lung Cancer Study Results
- Shareholder Update
- Australian Patent Issued
- Publication of BARD1 Lung Cancer Test
- Appendix 4E Preliminary Financial Results
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq